D. Baer

486 total citations
7 papers, 372 citations indexed

About

D. Baer is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, D. Baer has authored 7 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in D. Baer's work include Lymphoma Diagnosis and Treatment (2 papers), Iron Metabolism and Disorders (2 papers) and Lung Cancer Treatments and Mutations (2 papers). D. Baer is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Iron Metabolism and Disorders (2 papers) and Lung Cancer Treatments and Mutations (2 papers). D. Baer collaborates with scholars based in United States. D. Baer's co-authors include Leo B. Hurley, Irene S. Tekawa, C. P. Quesenberry, Bruce Fireman, Arnold L. Potosky, Martin L. Brown, Carol P. Somkin, A. Jacobson, Lisa J. Herrinton and G D Friedman and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and American Journal of Epidemiology.

In The Last Decade

D. Baer

7 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Baer United States	6	130	110	99	86	71	7	372
Elwood Headley United States	4	110 0.8×	150 1.4×	31 0.3×	19 0.2×	80 1.1×	8	475
Charles D. Cobau United States	8	276 2.1×	25 0.2×	28 0.3×	81 0.9×	105 1.5×	18	556
Saskia de Groot Netherlands	12	114 0.9×	76 0.7×	171 1.7×	22 0.3×	109 1.5×	35	440
Manal O. Elnenaei Canada	14	121 0.9×	70 0.6×	9 0.1×	137 1.6×	51 0.7×	34	466
Noortje Thielen Netherlands	11	143 1.1×	212 1.9×	45 0.5×	44 0.5×	67 0.9×	22	508
Dinara Makenbaeva United States	13	96 0.7×	233 2.1×	84 0.8×	13 0.2×	25 0.4×	46	606
Xiting Cao United States	14	255 2.0×	44 0.4×	60 0.6×	39 0.5×	248 3.5×	45	683
Nitya Nathwani United States	12	186 1.4×	198 1.8×	19 0.2×	49 0.6×	27 0.4×	37	528
G. P. Summerfield United Kingdom	11	36 0.3×	166 1.5×	17 0.2×	55 0.6×	20 0.3×	21	304
Monique Steijaert Netherlands	12	285 2.2×	281 2.6×	24 0.2×	151 1.8×	39 0.5×	13	615

Countries citing papers authored by D. Baer

Since Specialization

Citations

This map shows the geographic impact of D. Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Baer more than expected).

Fields of papers citing papers by D. Baer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Baer. The network helps show where D. Baer may publish in the future.

Co-authorship network of co-authors of D. Baer

This figure shows the co-authorship network connecting the top 25 collaborators of D. Baer. A scholar is included among the top collaborators of D. Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Baer. D. Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Advani, Ranjana H., Richard T. Hoppe, D. Baer, et al.. (2012). Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. Annals of Oncology. 24(4). 1044–1048. 17 indexed citations

2.

Kolevska, Tatjana, Charles J. Ryan, Lawrence S. Weisberg, et al.. (2009). Phase II trial of nab-paclitaxel as first-line therapy of hormone refractory metastatic prostate cancer (HRPC). Journal of Clinical Oncology. 27(15_suppl). 5152–5152. 3 indexed citations

3.

Fireman, Bruce, C. P. Quesenberry, Carol P. Somkin, et al.. (1997). Cost of care for cancer in a health maintenance organization.. PubMed. 18(4). 51–76. 170 indexed citations

4.

Horning, Sandra J., R T Hoppe, Byron W. Brown, et al.. (1997). Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.. Journal of Clinical Oncology. 15(5). 1736–1744. 53 indexed citations

5.

Herrinton, Lisa J., G D Friedman, D. Baer, & Joseph V. Selby. (1995). Transferrin Saturation and Risk of Cancer. American Journal of Epidemiology. 142(7). 692–698. 44 indexed citations

6.

Baer, D., et al.. (1995). Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F. Human Genetics. 96(3). 339–42. 10 indexed citations

7.

Baer, D., Irene S. Tekawa, & Leo B. Hurley. (1994). Iron stores are not associated with acute myocardial infarction.. Circulation. 89(6). 2915–2918. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact